EUR 69.8
(0.14%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 411.71 Million EUR | 19.62% |
2022 | 344.19 Million EUR | 39.16% |
2021 | 247.34 Million EUR | 10.83% |
2020 | 223.16 Million EUR | 7.26% |
2019 | 208.06 Million EUR | -1.72% |
2018 | 211.7 Million EUR | 39.95% |
2017 | 151.27 Million EUR | 8.33% |
2016 | 139.64 Million EUR | 7.67% |
2015 | 129.69 Million EUR | 19.87% |
2014 | 108.18 Million EUR | 6.1% |
2013 | 101.96 Million EUR | 0.79% |
2012 | 101.16 Million EUR | 25.8% |
2011 | 80.42 Million EUR | 17.68% |
2010 | 68.33 Million EUR | 16.24% |
2009 | 58.78 Million EUR | 6.17% |
2008 | 55.37 Million EUR | 2.25% |
2007 | 54.15 Million EUR | 5.06% |
2006 | 51.54 Million EUR | 7.54% |
2005 | 47.93 Million EUR | 0.31% |
2004 | 47.78 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 423.55 Million EUR | -2.6% |
2024 Q1 | 434.86 Million EUR | 5.62% |
2024 Q3 | 415.34 Million EUR | -1.94% |
2023 Q2 | 375.95 Million EUR | 0.78% |
2023 FY | 411.71 Million EUR | 19.62% |
2023 Q3 | 399.71 Million EUR | 6.32% |
2023 Q4 | 411.71 Million EUR | 3.0% |
2023 Q1 | 373.02 Million EUR | 8.38% |
2022 Q2 | 262.99 Million EUR | -2.41% |
2022 Q1 | 269.47 Million EUR | 8.95% |
2022 FY | 344.19 Million EUR | 39.16% |
2022 Q4 | 344.19 Million EUR | 3.16% |
2022 Q3 | 333.66 Million EUR | 26.87% |
2021 Q3 | 249.5 Million EUR | -1.45% |
2021 Q1 | 250.98 Million EUR | 12.47% |
2021 FY | 247.34 Million EUR | 10.83% |
2021 Q4 | 247.34 Million EUR | -0.87% |
2021 Q2 | 253.17 Million EUR | 0.87% |
2020 Q3 | 220.55 Million EUR | -0.21% |
2020 FY | 223.16 Million EUR | 7.26% |
2020 Q4 | 223.16 Million EUR | 1.18% |
2020 Q2 | 221.01 Million EUR | -4.73% |
2020 Q1 | 231.98 Million EUR | 11.49% |
2019 Q3 | 209.77 Million EUR | -2.9% |
2019 Q4 | 208.06 Million EUR | -0.81% |
2019 Q1 | 224.73 Million EUR | 6.15% |
2019 FY | 208.06 Million EUR | -1.72% |
2019 Q2 | 216.03 Million EUR | -3.87% |
2018 FY | 211.7 Million EUR | 39.95% |
2018 Q1 | 175.98 Million EUR | 16.33% |
2018 Q4 | 211.7 Million EUR | 23.04% |
2018 Q3 | 172.06 Million EUR | -3.13% |
2018 Q2 | 177.62 Million EUR | 0.94% |
2017 FY | 151.27 Million EUR | 8.33% |
2017 Q4 | 151.27 Million EUR | -0.94% |
2017 Q3 | 152.72 Million EUR | -0.41% |
2017 Q2 | 153.34 Million EUR | -6.83% |
2017 Q1 | 164.58 Million EUR | 17.87% |
2016 Q3 | 144.66 Million EUR | 1.91% |
2016 Q2 | 141.95 Million EUR | -3.44% |
2016 Q1 | 147.01 Million EUR | 13.36% |
2016 Q4 | 139.64 Million EUR | -3.47% |
2016 FY | 139.64 Million EUR | 7.67% |
2015 Q2 | 135.51 Million EUR | -8.86% |
2015 Q1 | 148.68 Million EUR | 37.43% |
2015 Q3 | 130.05 Million EUR | -4.03% |
2015 Q4 | 129.69 Million EUR | -0.28% |
2015 FY | 129.69 Million EUR | 19.87% |
2014 Q2 | 100.82 Million EUR | -7.11% |
2014 FY | 108.18 Million EUR | 6.1% |
2014 Q4 | 108.18 Million EUR | 5.71% |
2014 Q3 | 102.34 Million EUR | 1.51% |
2014 Q1 | 108.54 Million EUR | 6.45% |
2013 Q1 | 105.12 Million EUR | 3.91% |
2013 Q3 | 102.48 Million EUR | 2.66% |
2013 Q4 | 101.96 Million EUR | -0.5% |
2013 FY | 101.96 Million EUR | 0.79% |
2013 Q2 | 99.82 Million EUR | -5.04% |
2012 Q2 | 81.16 Million EUR | -5.13% |
2012 FY | 101.16 Million EUR | 25.8% |
2012 Q3 | 83.74 Million EUR | 3.18% |
2012 Q4 | 101.16 Million EUR | 20.8% |
2012 Q1 | 85.55 Million EUR | 6.39% |
2011 Q1 | 73.23 Million EUR | 7.17% |
2011 FY | 80.42 Million EUR | 17.68% |
2011 Q2 | 75.46 Million EUR | 3.04% |
2011 Q3 | 77.27 Million EUR | 2.41% |
2011 Q4 | 80.42 Million EUR | 4.07% |
2010 Q1 | 63.14 Million EUR | 7.41% |
2010 Q2 | 62.14 Million EUR | -1.58% |
2010 FY | 68.33 Million EUR | 16.24% |
2010 Q3 | 63.51 Million EUR | 2.19% |
2010 Q4 | 68.33 Million EUR | 7.6% |
2009 FY | 58.78 Million EUR | 6.17% |
2009 Q4 | 58.78 Million EUR | 0.0% |
2008 FY | 55.37 Million EUR | 2.25% |
2007 FY | 54.15 Million EUR | 5.06% |
2006 FY | 51.54 Million EUR | 7.54% |
2005 FY | 47.93 Million EUR | 0.31% |
2004 FY | 47.78 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
DocCheck AG | 59.1 Million EUR | -596.549% |
CompuGroup Medical SE & Co. KGaA | 1.89 Billion EUR | 78.33% |
MeVis Medical Solutions AG | 28.05 Million EUR | -1367.587% |